Janux Therapeutics Correlations

JANX Stock

USD 46.39 1.61 3.35%

The current 90-days correlation between Janux Therapeutics and Keros Therapeutics is 0.11 (i.e., Average diversification). The correlation of Janux Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Janux Therapeutics Correlation With Market

Average diversification

The correlation between Janux Therapeutics and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

Moving together with Janux Stock

0.72	EWTX	Edgewise Therapeutics	Pair Corr
0.67	BHC	Bausch Health Companies	Pair Corr
0.67	GANX	Gain Therapeutics	Pair Corr
0.72	GILD	Gilead Sciences	Pair Corr
0.79	CPRX	Catalyst Pharmaceuticals	Pair Corr

Moving against Janux Stock

0.7	ELAN	Elanco Animal Health Potential Growth	Pair Corr
0.55	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.51	TAK	Takeda Pharmaceutical	Pair Corr
0.5	HLN	Haleon plc	Pair Corr
0.43	ZTS	Zoetis Inc	Pair Corr
0.42	RDY	Dr Reddys Laboratories	Pair Corr
0.35	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.33	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.57	CTLT	Catalent	Pair Corr
0.56	ANRO	Alto Neuroscience,	Pair Corr
0.36	DRMAW	Dermata Therapeutics	Pair Corr

Related Correlations Analysis

	MLYS	ELYM	ANEB	RZLT	KROS	FENC	EWTX	HRMY	MOLN	MNOV
MLYS		-0.54	-0.18	0.44	0.67	-0.51	0.73	-0.39	0.25	-0.25	MLYS
ELYM	-0.54		0.7	-0.38	-0.46	0.48	-0.79	0.64	-0.27	-0.06	ELYM
ANEB	-0.18	0.7		-0.15	-0.15	0.16	-0.33	0.56	-0.3	-0.11	ANEB
RZLT	0.44	-0.38	-0.15		0.57	-0.4	0.48	-0.16	0.44	-0.24	RZLT
KROS	0.67	-0.46	-0.15	0.57		-0.59	0.72	-0.15	-0.09	0.16	KROS
FENC	-0.51	0.48	0.16	-0.4	-0.59		-0.64	0.48	0.08	-0.02	FENC
EWTX	0.73	-0.79	-0.33	0.48	0.72	-0.64		-0.48	0.1	0.03	EWTX
HRMY	-0.39	0.64	0.56	-0.16	-0.15	0.48	-0.48		-0.25	0.06	HRMY
MOLN	0.25	-0.27	-0.3	0.44	-0.09	0.08	0.1	-0.25		-0.51	MOLN
MNOV	-0.25	-0.06	-0.11	-0.24	0.16	-0.02	0.03	0.06	-0.51		MNOV
	MLYS	ELYM	ANEB	RZLT	KROS	FENC	EWTX	HRMY	MOLN	MNOV

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EWTX	+ 0.73	MLYS
EWTX	+ 0.72	KROS
ANEB	+ 0.7	ELYM
KROS	+ 0.67	MLYS
HRMY	+ 0.64	ELYM
KROS	+ 0.57	RZLT

High negative correlations

EWTX	- 0.79	ELYM
EWTX	- 0.64	FENC
FENC	- 0.59	KROS
ELYM	- 0.54	MLYS
MNOV	- 0.51	MOLN
FENC	- 0.51	MLYS

Risk-Adjusted Indicators

There is a big difference between Janux Stock performing well and Janux Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Janux Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MLYS	2.68	(0.10)	0.02	0.07	3.38	(2.78)	6.27	(5.79)	20.98
ELYM	3.87	(0.92)	0.00	(2.63)	0.00	0.00	6.21	(9.35)	34.87
ANEB	5.00	(0.35)	0.00	(0.12)	0.00	0.00	8.61	(11.48)	76.00
RZLT	2.78	(0.03)	0.01	0.09	3.11	(3.21)	6.80	(5.54)	30.01
KROS	2.09	0.26	0.12	0.30	2.19	(2.25)	4.39	(4.31)	16.94
FENC	3.19	(0.03)	0.01	0.10	3.78	(3.81)	7.14	(6.68)	23.48
EWTX	3.45	0.63	0.24	0.34	2.79	(3.95)	6.65	(4.70)	61.02
HRMY	2.20	(0.05)	(0.01)	0.07	4.07	(2.15)	3.62	(3.53)	34.59
MOLN	4.53	(0.20)	0.00	(0.02)	0.00	0.00	9.38	(8.53)	52.92
MNOV	4.87	1.03	0.12	(0.34)	4.38	(6.70)	12.43	(8.50)	61.30

Janux Therapeutics Corporate Management

Brenda Vreeswyk	Head Resources	Profile
Byron JD	Chief Officer	Profile
Wayne MD	Chief Officer	Profile
Tommy Diraimondo	Director Research	Profile
Matt Whitmire	Vice Finance	Profile
Charles Winter	Manufacturing Chemistry	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC